tosufloxacin has been researched along with Infections, Respiratory in 7 studies
tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "By using broth microdilution methods, the in vitro activity of tosufloxacin (A-64730), a new quinolone, was compared with those of other agents, including five quinolones, against geographically diverse cystic fibrosis sputum isolates obtained from 26 cystic fibrosis centers in the United States." | 7.68 | In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum. ( Akaniro, JC; Arguedas, AG; Marks, MI; Stutman, HR, 1990) |
| "By using broth microdilution methods, the in vitro activity of tosufloxacin (A-64730), a new quinolone, was compared with those of other agents, including five quinolones, against geographically diverse cystic fibrosis sputum isolates obtained from 26 cystic fibrosis centers in the United States." | 3.68 | In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum. ( Akaniro, JC; Arguedas, AG; Marks, MI; Stutman, HR, 1990) |
| "Tosufloxacin was the most potent of all the antibiotics tested for antibacterial activity against S." | 1.33 | Antibacterial activity of tosufloxacin against major organisms detected from patients with respiratory or otorhinological infections: comparison with the results obtained from organisms isolated about 10 years ago. ( Amano, A; Hasegawa, M; Kanayama, A; Kobayashi, I; Matsuzaki, K; Muraoka, H; Saika, T; Sato, Y, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sunakawa, K | 1 |
| Onai, K | 1 |
| Yamazaki, T | 1 |
| Hasegawa, M | 2 |
| Sato, Y | 2 |
| Kanayama, A | 1 |
| Matsuzaki, K | 2 |
| Muraoka, H | 1 |
| Amano, A | 1 |
| Saika, T | 1 |
| Kobayashi, I | 2 |
| Takahama, H | 1 |
| Tazaki, H | 1 |
| Omika, K | 1 |
| Yamaguchi, K | 1 |
| Miyazaki, S | 1 |
| Kashitani, F | 1 |
| Iwata, M | 1 |
| Kanda, M | 1 |
| Tsujio, Y | 1 |
| Okada, J | 1 |
| Tazawa, Y | 1 |
| Watanabe, N | 1 |
| Uehara, N | 1 |
| Igari, J | 1 |
| Oguri, T | 1 |
| Kaimori, M | 1 |
| Kawamura, C | 1 |
| Iinuma, Y | 1 |
| Nisawataira, T | 1 |
| Tashiro, H | 1 |
| Ueno, K | 1 |
| Ishigo, S | 1 |
| Yasujima, M | 1 |
| Kawahara, S | 1 |
| Itoh, C | 1 |
| Yoshida, T | 1 |
| Yamanaka, K | 1 |
| Toyoshima, S | 1 |
| Katoh, J | 1 |
| Kudoh, M | 1 |
| Matsushima, T | 1 |
| Niki, Y | 1 |
| Miyashita, N | 1 |
| Funato, T | 1 |
| Kaku, M | 1 |
| Sato, N | 1 |
| Saito, Y | 1 |
| Ishii, K | 1 |
| Kuwabara, M | 1 |
| Hongo, T | 1 |
| Negayama, K | 1 |
| Kamihira, S | 1 |
| Miyazaki, Y | 1 |
| Takii, M | 1 |
| Ishii, M | 1 |
| Nakagawa, K | 1 |
| Ono, J | 1 |
| Takada, T | 1 |
| Murakami, N | 1 |
| Taira, M | 1 |
| Tamaki, I | 1 |
| Matsudou, Y | 1 |
| Nakasone, I | 1 |
| Kohno, S | 1 |
| Arguedas, AG | 1 |
| Akaniro, JC | 1 |
| Stutman, HR | 1 |
| Marks, MI | 1 |
1 review available for tosufloxacin and Infections, Respiratory
| Article | Year |
|---|---|
Clinical assessment of tosufloxacin tosilate.
Topics: Anti-Infective Agents; Community-Acquired Infections; Fluoroquinolones; Humans; Microbial Sensitivit | 2002 |
6 other studies available for tosufloxacin and Infections, Respiratory
| Article | Year |
|---|---|
[Intractable pediatric infectious disease: examining the ability of a new drug, tosufloxacin tosilate hydrate for pediatric (discussion)].
Topics: Administration, Oral; Age Factors; Anti-Bacterial Agents; Bacterial Infections; Child; Fluoroquinolo | 2011 |
Antibacterial activity of tosufloxacin against major organisms detected from patients with respiratory or otorhinological infections: comparison with the results obtained from organisms isolated about 10 years ago.
Topics: Drug Resistance, Bacterial; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity | 2006 |
Tosufloxacin tosilate-induced thrombocytopenic purpura.
Topics: Aged; Anti-Infective Agents; Drug Hypersensitivity; Fluoroquinolones; Humans; Male; Naphthyridines; | 2007 |
[Antibacterial activity of tosufloxacin against major organisms detected from patients with respiratory infections].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Klebsiella p | 2007 |
[Activities of antimicrobial agents against 5,180 clinical isolates obtained from 26 medical institutions during 1998 in Japan. Levofloxacin--Surveillance Group].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Ba | 2000 |
In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Culture Media; Cystic Fibrosis; Fluoroquinolones; Hum | 1990 |